Companies Dominating the Drug Delivery Devices Landscape
- Antares Pharma, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Novartis International AG
- Johnson & Johnson
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Otsuka Pharmaceutical Co., Ltd.,
- Abbott Laboratories
- Cipla Limited
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Drug Delivery Devices Market in 2025 is evaluated at USD 315.95 billion.
The global market size was worth more than USD 301.94 billion in 2024 and is poised to witness a CAGR of over 5.8%, crossing USD 628.4 billion revenue by 2037.
North America is anticipated to generate largest share by 2037, driven by increased product releases and initiatives by leading industry participants, along with rising cancer cases in the region.
The major players in the market include Antares Pharma, Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Novartis International AG, Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Cipla Limited.
